Meropen (Meropenem)


Indications and Reactions:

Role Indications Reactions
Secondary
Pneumonia 16.4%
Prophylaxis 14.5%
Infection 12.7%
Antifungal Prophylaxis 10.9%
Peripheral T-cell Lymphoma Unspecified 10.9%
Non-small Cell Lung Cancer 7.3%
Sepsis 5.5%
Acute Leukaemia 3.6%
Aspergillosis 3.6%
Drug Use For Unknown Indication 3.6%
Neutrophil Count Decreased 3.6%
Acute Myeloid Leukaemia Recurrent 1.8%
Graft Versus Host Disease 1.8%
Neutrophil Count Increased 1.8%
Systemic Candida 1.8%
Rash 18.8%
Photophobia 12.5%
Renal Failure 12.5%
Toxic Epidermal Necrolysis 12.5%
Gamma-glutamyltransferase Increased 6.3%
Pseudomembranous Colitis 6.3%
Pyrexia 6.3%
Sepsis 6.3%
Swelling 6.3%
Viral Infection 6.3%
Wheezing 6.3%
Concomitant
Multiple Myeloma 19.7%
Bronchopulmonary Aspergillosis 13.8%
Drug Use For Unknown Indication 12.6%
Acute Myeloid Leukaemia 9.8%
Acute Myeloid Leukaemia Recurrent 6.3%
Lung Transplant 6.3%
Fungal Infection 5.1%
Pneumonia 3.5%
Bone Marrow Transplant 2.4%
Sedation 2.4%
Aspergillosis 2.0%
Febrile Neutropenia 2.0%
Graft Versus Host Disease 2.0%
Infection 2.0%
Lupus Nephritis 2.0%
Staphylococcal Infection 2.0%
Haemolysis 1.6%
Ill-defined Disorder 1.6%
Non-hodgkin's Lymphoma 1.6%
Rheumatoid Arthritis 1.6%
White Blood Cell Count Decreased 24.8%
Weight Increased 7.4%
Platelet Count Decreased 6.6%
Ventricular Extrasystoles 6.6%
Ventricular Tachycardia 6.6%
Respiratory Failure 5.8%
Pyrexia 4.1%
Renal Impairment 4.1%
Renal Failure Acute 3.3%
Sepsis 3.3%
Urine Output Decreased 3.3%
Venoocclusive Liver Disease 3.3%
White Blood Cell Count Increased 3.3%
Hypokalaemia 2.5%
Pneumonia Cytomegaloviral 2.5%
Renal Disorder 2.5%
Septic Shock 2.5%
Shock 2.5%
Thrombocytopenia 2.5%
Transplant Rejection 2.5%

Drug Data